Robot-assisted Approach to Cervical Cancer
The purpose of the RACC trial is to compare the oncologic outcome defined as recurrence-free survival (RFS) between robot-assisted and open radical hysterectomy for the treatment of early stage cervical cancer.
• Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adeno-squamous carcinoma of the uterine cervix;
• Patients with histologically confirmed stage IB (IB3 excluded) and IIA1, according to the latest revision of the FIGO staging manual
• Patients undergoing either a Type B or C radical hysterectomy (Querleu and Morrow classification)
• Patients with adequate bone marrow, renal and hepatic function
• ECOG Performance Status of 0, 1 or 2.
• Patient must be suitable candidates for surgery.
• Patients who have signed an approved Informed Consent
• Age 18 years or older